187 related articles for article (PubMed ID: 31730712)
1. Platinum exposure and cause-specific mortality among patients with testicular cancer.
Groot HJ; van Leeuwen FE; Lubberts S; Horenblas S; de Wit R; Witjes JA; Groenewegen G; Poortmans PM; Hulshof MCCM; Meijer OWM; de Jong IJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJB; Jóźwiak K; van den Belt-Dusebout AW; Gietema JA; Schaapveld M
Cancer; 2020 Feb; 126(3):628-639. PubMed ID: 31730712
[TBL] [Abstract][Full Text] [Related]
2. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
Groot HJ; Lubberts S; de Wit R; Witjes JA; Kerst JM; de Jong IJ; Groenewegen G; van den Eertwegh AJM; Poortmans PM; Klümpen HJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJ; Incrocci L; van den Bergh ACM; Jóźwiak K; van den Belt-Dusebout AW; Horenblas S; Gietema JA; van Leeuwen FE; Schaapveld M
J Clin Oncol; 2018 Aug; 36(24):2504-2513. PubMed ID: 29989856
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in stage I testicular seminoma: a population-based study of 9193 patients.
Beard CJ; Travis LB; Chen MH; Arvold ND; Nguyen PL; Martin NE; Kuban DA; Ng AK; Hoffman KE
Cancer; 2013 Aug; 119(15):2771-7. PubMed ID: 23633409
[TBL] [Abstract][Full Text] [Related]
4. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
5. Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer: A Danish Nationwide Cohort Study.
Kier MG; Hansen MK; Lauritsen J; Mortensen MS; Bandak M; Agerbaek M; Holm NV; Dalton SO; Andersen KK; Johansen C; Daugaard G
JAMA Oncol; 2016 Dec; 2(12):1624-1627. PubMed ID: 27711914
[TBL] [Abstract][Full Text] [Related]
6. Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort.
Hellesnes R; Myklebust TÅ; Fosså SD; Bremnes RM; Karlsdottir Á; Kvammen Ø; Tandstad T; Wilsgaard T; Negaard HFS; Haugnes HS
J Clin Oncol; 2021 Nov; 39(32):3561-3573. PubMed ID: 34388002
[TBL] [Abstract][Full Text] [Related]
7. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
8. [Late toxicity after chemotherapy of malignant testicular tumors].
Jakob A; Kollmannsberger C; Kanz L; Bokemeyer C
Urologe A; 1998 Nov; 37(6):635-47. PubMed ID: 9887493
[TBL] [Abstract][Full Text] [Related]
9. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
Fung C; Fossa SD; Milano MT; Oldenburg J; Travis LB
J Clin Oncol; 2013 Oct; 31(30):3807-14. PubMed ID: 24043737
[TBL] [Abstract][Full Text] [Related]
10. Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.
Hellesnes R; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Kvammen Ø; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
J Clin Oncol; 2021 Feb; 39(4):308-318. PubMed ID: 33356420
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
12. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival.
Patel HD; Srivastava A; Alam R; Joice GA; Schwen ZR; Semerjian A; Allaf ME; Pierorazio PM
Urol Oncol; 2017 Oct; 35(10):606.e1-606.e7. PubMed ID: 28712791
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.
Fung C; Fossa SD; Milano MT; Sahasrabudhe DM; Peterson DR; Travis LB
J Clin Oncol; 2015 Oct; 33(28):3105-15. PubMed ID: 26240226
[TBL] [Abstract][Full Text] [Related]
15. Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer.
Blok JM; Groot HJ; Huele EH; de Wit R; Horenblas S; Nuver J; Groenewegen G; Bosch JLHR; Witjes JA; Tromp JM; de Brouwer PJM; van den Berg HA; Vanneste BGL; Smilde TJ; Aarts MJB; Gietema JA; Meijer RP; Schaapveld M
J Clin Oncol; 2021 Feb; 39(4):319-327. PubMed ID: 33119475
[TBL] [Abstract][Full Text] [Related]
16. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
Li H; Zhu C; Wu J; Ma Y; Jin X; Wei X; Wang K; Li H
Int Urol Nephrol; 2021 Mar; 53(3):471-477. PubMed ID: 33052518
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
18. Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers.
Schairer C; Hisada M; Chen BE; Brown LM; Howard R; Fosså SD; Gail M; Travis LB
J Natl Cancer Inst; 2007 Aug; 99(16):1248-56. PubMed ID: 17686826
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
20. Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.
Hellesnes R; Kvammen Ø; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
Int J Cancer; 2020 Jul; 147(1):21-32. PubMed ID: 31597192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]